0001209191-21-041814.txt : 20210617 0001209191-21-041814.hdr.sgml : 20210617 20210617214603 ACCESSION NUMBER: 0001209191-21-041814 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walkey Carl CENTRAL INDEX KEY: 0001843189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 211026952 MAIL ADDRESS: STREET 1: C/O NEOLEUKIN THERAPEUTICS, INC. STREET 2: 360-1616 EASTLAKE AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neoleukin Therapeutics, Inc. CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-732-2133 MAIL ADDRESS: STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC DATE OF NAME CHANGE: 20140128 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-16 0 0001404644 Neoleukin Therapeutics, Inc. NLTX 0001843189 Walkey Carl CO NEOLEUKIN THERAPEUTICS, INC. 188 EAST BLAINE STREET, #450 SEATTLE WA 98102 0 1 0 0 Senior Vice President Common Stock 2021-06-16 4 S 0 600 10.19 D 1352489 D This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. /s/ Kris McGrew, as Attorney-in-Fact for Carl Walkey 2021-06-17